PHASE I STUDY OF AZOTOMYCIN (NSC-56654).
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D000970:Antineoplastic Agents; D001391:Azo Compounds; D003879:Dermatologic Agents; D004358:Drug Therapy; D014116:Toxicology
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D000970:Antineoplastic Agents; D001391:Azo Compounds; D003879:Dermatologic Agents; C100225:azotomycin
ANTIBIOTICS; ANTINEOPLASTIC AGENTS; DRUG THERAPY; TOXICOLOGIC REPORT